Clinical Trials Directory

Trials / Completed

CompletedNCT03378999

Rhodospirillum Rubrum and Cholesterol

A Proof of Concept Study to Demonstrate a Cholesterol-lowering Benefit of Oven-dried Rhodospirillum Rubrum

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
82 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
Male
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The primary objective of the study is to examine for the first time the LDL cholesterol lowering effect of oven-dried Rhodospirillum rubrum in humans.

Detailed description

Objectives: Secondary objectives are to investigate the effects on other CVD risk parameters: total cholesterol, triacylglycerol, HDL-C, glucose and blood pressure. Safety will be monitored by measurements of markers for liver, kidney and heart function. Study design: The study is a 4-weeks randomized, double-blind placebo-controlled trial with a parallel design using 3 doses oven-dried Rhodospirillum rubrum. Prior to and after the intervention period, a 2-week run-in and run-out period takes place, during which all subjects will consume placebo capsules. Study population: Eighty (N=80) healthy men with a slightly elevated fasting serum total cholesterol concentration (between 5.0-8.0 mmol/l) will complete the study. Intervention: During the intervention period of 4 weeks, men will receive either placebo or capsules containing 0.25 gr, 0.5 gr or 1.0 gr oven-dried Rhodospirillum rubrum per day.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRhodospirillum rubrumCapsules containing oven-dried Rhodospirillum rubrum
DIETARY_SUPPLEMENTControlCapsules containing microcrystalline cellulose

Timeline

Start date
2018-06-14
Primary completion
2019-05-10
Completion
2019-05-10
First posted
2017-12-20
Last updated
2019-05-24

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03378999. Inclusion in this directory is not an endorsement.